CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 414 filers reported holding CRISPR THERAPEUTICS AG in Q4 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,003,428 | +2289.1% | 22,185 | +6386.8% | 0.03% | +1250.0% |
Q1 2021 | $42,000 | -8.7% | 342 | +12.9% | 0.00% | 0.0% |
Q4 2020 | $46,000 | -90.1% | 303 | -94.6% | 0.00% | -92.3% |
Q3 2020 | $467,000 | +54.6% | 5,588 | +35.9% | 0.03% | -48.0% |
Q2 2020 | $302,000 | +231.9% | 4,111 | +91.4% | 0.05% | +2.0% |
Q1 2020 | $91,000 | +68.5% | 2,148 | +140.3% | 0.05% | +345.5% |
Q4 2019 | $54,000 | – | 894 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $27,989,046 | 33.20% |
Gilfoyle Management LLC | 100 | $4,842 | 15.90% |
NEA Management Company, LLC | 1,587,854 | $89,142,124 | 6.80% |
ARK Investment Management | 7,338,447 | $411,980,394 | 2.73% |
Nikko Asset Management Americas, Inc. | 3,533,357 | $198,327,328 | 2.09% |
Del-Sette Capital Management, LLC | 33,661 | $1,889,729 | 1.79% |
Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
Merlin Capital, Inc | 8,802 | $494,144 | 1.67% |
Green Alpha Advisors, LLC | 34,373 | $1,929,700 | 1.27% |